Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults.

Meade P, Kuan G, Strohmeier S, Maier HE, Amanat F, Balmaseda A, Ito K, Kirkpatrick E, Javier A, Gresh L, Nachbagauer R, Gordon A, Krammer F.

mBio. 2020 Jan 21;11(1). pii: e03243-19. doi: 10.1128/mBio.03243-19.

2.

Genetic risk for dengue hemorrhagic fever and dengue fever in multiple ancestries.

Pare G, Neupane B, Eskandarian S, Harris E, Halstead S, Gresh L, Kuan G, Balmaseda A, Villar L, Rojas E, Osorio JE, Anh DD, De Silva AD, Premawansa S, Premawansa G, Wijewickrama A, Lorenzana I, Parham L, Rodriguez C, Fernandez-Salas I, Sanchez-Casas R, Diaz-Gonzalez EE, Saw Aye K, May WL, Thein M, Bucardo F, Reyes Y, Blandon P, Hirayama K, Weiss L, Singh P, Newton J, Loeb M; Dengue Population Genetics Program.

EBioMedicine. 2020 Jan;51:102584. doi: 10.1016/j.ebiom.2019.11.045. Epub 2020 Jan 2.

3.

Age-dependent manifestations and case definitions of paediatric Zika: a prospective cohort study.

Burger-Calderon R, Bustos Carrillo F, Gresh L, Ojeda S, Sanchez N, Plazaola M, Katzelnick L, Mercado BL, Monterrey JC, Elizondo D, Arguello S, Nuñez A, Gordon A, Balmaseda A, Kuan G, Harris E.

Lancet Infect Dis. 2020 Mar;20(3):371-380. doi: 10.1016/S1473-3099(19)30547-X. Epub 2019 Dec 20.

PMID:
31870907
4.

Association between the respiratory microbiome and susceptibility to influenza virus infection.

Tsang TK, Lee KH, Foxman B, Balmaseda A, Gresh L, Sanchez N, Ojeda S, Lopez R, Yang Y, Kuan G, Gordon A.

Clin Infect Dis. 2019 Sep 28. pii: ciz968. doi: 10.1093/cid/ciz968. [Epub ahead of print]

PMID:
31562814
5.

Underdetection of laboratory-confirmed influenza-associated hospital admissions among infants: a multicentre, prospective study.

Thompson MG, Levine MZ, Bino S, Hunt DR, Al-Sanouri TM, Simões EAF, Porter RM, Biggs HM, Gresh L, Simaku A, Khader IA, Tallo VL, Meece JK, McMorrow M, Mercado ES, Joshi S, DeGroote NP, Hatibi I, Sanchez F, Lucero MG, Faouri S, Jefferson SN, Maliqari N, Balmaseda A, Sanvictores D, Holiday C, Sciuto C, Owens Z, Azziz-Baumgartner E, Gordon A.

Lancet Child Adolesc Health. 2019 Nov;3(11):781-794. doi: 10.1016/S2352-4642(19)30246-9. Epub 2019 Sep 3.

6.

Pre-existing anti-neuraminidase antibodies are associated with shortened duration of influenza A (H1N1)pdm virus shedding and illness in naturally infected adults.

Maier HE, Nachbagauer R, Kuan G, Ng S, Lopez R, Sanchez N, Stadlbauer D, Gresh L, Schiller A, Rajabhathor A, Ojeda S, Guglia AF, Amanat F, Balmaseda A, Krammer F, Gordon A.

Clin Infect Dis. 2019 Jul 12. pii: ciz639. doi: 10.1093/cid/ciz639. [Epub ahead of print]

PMID:
31300819
7.

Assessing the Incidence of Symptomatic Respiratory Syncytial Virus (RSV) Illness within a Prospective Birth Cohort in Managua, Nicaragua.

Kubale J, Kuan G, Gresh L, Ojeda S, Azziz-Baumgartner E, Sanchez N, Lopez R, Harris E, Balmaseda A, Gordon A.

Clin Infect Dis. 2019 Jun 29. pii: ciz585. doi: 10.1093/cid/ciz585. [Epub ahead of print]

PMID:
31257406
8.

Novel correlates of protection against pandemic H1N1 influenza A virus infection.

Ng S, Nachbagauer R, Balmaseda A, Stadlbauer D, Ojeda S, Patel M, Rajabhathor A, Lopez R, Guglia AF, Sanchez N, Amanat F, Gresh L, Kuan G, Krammer F, Gordon A.

Nat Med. 2019 Jun;25(6):962-967. doi: 10.1038/s41591-019-0463-x. Epub 2019 Jun 3.

9.

Effects of infection history on dengue virus infection and pathogenicity.

Tsang TK, Ghebremariam SL, Gresh L, Gordon A, Halloran ME, Katzelnick LC, Rojas DP, Kuan G, Balmaseda A, Sugimoto J, Harris E, Longini IM Jr, Yang Y.

Nat Commun. 2019 Mar 18;10(1):1246. doi: 10.1038/s41467-019-09193-y.

10.

Prior dengue virus infection and risk of Zika: A pediatric cohort in Nicaragua.

Gordon A, Gresh L, Ojeda S, Katzelnick LC, Sanchez N, Mercado JC, Chowell G, Lopez B, Elizondo D, Coloma J, Burger-Calderon R, Kuan G, Balmaseda A, Harris E.

PLoS Med. 2019 Jan 22;16(1):e1002726. doi: 10.1371/journal.pmed.1002726. eCollection 2019 Jan.

11.

Epidemiological Evidence for Lineage-Specific Differences in the Risk of Inapparent Chikungunya Virus Infection.

Bustos Carrillo F, Collado D, Sanchez N, Ojeda S, Lopez Mercado B, Burger-Calderon R, Gresh L, Gordon A, Balmaseda A, Kuan G, Harris E.

J Virol. 2019 Feb 5;93(4). pii: e01622-18. doi: 10.1128/JVI.01622-18. Print 2019 Feb 15.

12.

Dynamics and determinants of the force of infection of dengue virus from 1994 to 2015 in Managua, Nicaragua.

Katzelnick LC, Ben-Shachar R, Mercado JC, Rodriguez-Barraquer I, Elizondo D, Arguello S, Nuñez A, Ojeda S, Sanchez N, Lopez Mercado B, Gresh L, Burger-Calderon R, Kuan G, Gordon A, Balmaseda A, Harris E.

Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10762-10767. doi: 10.1073/pnas.1809253115. Epub 2018 Sep 28.

13.

Influenza Transmission Dynamics in Urban Households, Managua, Nicaragua, 2012-2014.

Gordon A, Tsang TK, Cowling BJ, Kuan G, Ojeda S, Sanchez N, Gresh L, Lopez R, Balmaseda A, Harris E.

Emerg Infect Dis. 2018 Oct;24(10):1882-1888. doi: 10.3201/eid2410.161258.

14.

Obesity Increases the Duration of Influenza A Virus Shedding in Adults.

Maier HE, Lopez R, Sanchez N, Ng S, Gresh L, Ojeda S, Burger-Calderon R, Kuan G, Harris E, Balmaseda A, Gordon A.

J Infect Dis. 2018 Sep 22;218(9):1378-1382. doi: 10.1093/infdis/jiy370.

15.

Differing epidemiological dynamics of Chikungunya virus in the Americas during the 2014-2015 epidemic.

Tan Y, Pickett BE, Shrivastava S, Gresh L, Balmaseda A, Amedeo P, Hu L, Puri V, Fedorova NB, Halpin RA, LaPointe MP, Cone MR, Heberlein-Larson L, Kramer LD, Ciota AT, Gordon A, Shabman RS, Das SR, Harris E.

PLoS Negl Trop Dis. 2018 Jul 30;12(7):e0006670. doi: 10.1371/journal.pntd.0006670. eCollection 2018 Jul.

16.

Differences in Transmission and Disease Severity Between 2 Successive Waves of Chikungunya.

Gordon A, Gresh L, Ojeda S, Chowell G, Gonzalez K, Sanchez N, Saborio S, Mercado JC, Kuan G, Balmaseda A, Harris E.

Clin Infect Dis. 2018 Nov 13;67(11):1760-1767. doi: 10.1093/cid/ciy356.

17.

Antibody-dependent enhancement of severe dengue disease in humans.

Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, Balmaseda A, Harris E.

Science. 2017 Nov 17;358(6365):929-932. doi: 10.1126/science.aan6836. Epub 2017 Nov 2.

18.

Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.

Ng S, Saborio S, Kuan G, Gresh L, Sanchez N, Ojeda S, Harris E, Balmaseda A, Gordon A.

Vaccine. 2017 Oct 27;35(45):6202-6207. doi: 10.1016/j.vaccine.2017.09.036. Epub 2017 Oct 3.

19.

Development of in-house serological methods for diagnosis and surveillance of chikungunya.

Galo SS, González K, Téllez Y, García N, Pérez L, Gresh L, Harris E, Balmaseda Á.

Rev Panam Salud Publica. 2017 Aug 21;41:e56.

20.

Characterization of Dengue Virus Infections Among Febrile Children Clinically Diagnosed With a Non-Dengue Illness, Managua, Nicaragua.

Waggoner JJ, Gresh L, Mohamed-Hadley A, Balmaseda A, Soda KJ, Abeynayake J, Sahoo MK, Liu Y, Kuan G, Harris E, Pinsky BA.

J Infect Dis. 2017 Jun 15;215(12):1816-1823. doi: 10.1093/infdis/jix195.

21.

[An ethics call to include pregnant women in research: Reflections from the Global Forum on Bioethics in Research].

Saenz C, Alger J, Beca JP, Belizán JM, Cafferata ML, Guzmán JAC, Candanedo P JE, Duque L, Figueroa L, Garcés A, Gresh L, Gubert IC, Guilhem D, Guz G, Kaltwasser G, Lescano AR, Luna F, Cardelli AAM, Mastroleo I, Melamed IN, Del Carpio Toia AM, Palacios R, Palma GI, Salas SP, Sandoval X, de Siqueira SS, Vásquez H, de Vega BMV.

Rev Panam Salud Publica. 2017;41. pii: e13. Epub 2017 Feb 8. Spanish. No abstract available.

22.

Influenza and respiratory syncytial virus in infants study (IRIS) of hospitalized and non-ill infants aged <1 year in four countries: study design and methods.

Thompson MG, Hunt DR, Arbaji AK, Simaku A, Tallo VL, Biggs HM, Kulb C, Gordon A, Khader IA, Bino S, Lucero MG, Azziz-Baumgartner E, Shifflett P, Sanchez F, Marar BI, Bakalli I, Simões EA, Levine MZ, Meece JK, Balmaseda A, Al-Sanouri TM, Dhimolea M, de Jesus JN, Thornburg NJ, Gerber SI, Gresh L; IRIS Network.

BMC Infect Dis. 2017 Mar 22;17(1):222. doi: 10.1186/s12879-017-2299-7.

23.

Viremia and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and Dengue Virus.

Waggoner JJ, Gresh L, Vargas MJ, Ballesteros G, Tellez Y, Soda KJ, Sahoo MK, Nuñez A, Balmaseda A, Harris E, Pinsky BA.

Clin Infect Dis. 2016 Dec 15;63(12):1584-1590. Epub 2016 Aug 30.

24.

Seroprevalence of Anti-Chikungunya Virus Antibodies in Children and Adults in Managua, Nicaragua, After the First Chikungunya Epidemic, 2014-2015.

Kuan G, Ramirez S, Gresh L, Ojeda S, Melendez M, Sanchez N, Collado D, Garcia N, Mercado JC, Gordon A, Balmaseda A, Harris E.

PLoS Negl Trop Dis. 2016 Jun 20;10(6):e0004773. doi: 10.1371/journal.pntd.0004773. eCollection 2016 Jun.

25.

Single-Reaction Multiplex Reverse Transcription PCR for Detection of Zika, Chikungunya, and Dengue Viruses.

Waggoner JJ, Gresh L, Mohamed-Hadley A, Ballesteros G, Davila MJ, Tellez Y, Sahoo MK, Balmaseda A, Harris E, Pinsky BA.

Emerg Infect Dis. 2016 Jul;22(7):1295-7. doi: 10.3201/eid2207.160326. Epub 2016 Jul 15.

26.

Clinical evaluation of a single-reaction real-time RT-PCR for pan-dengue and chikungunya virus detection.

Waggoner JJ, Ballesteros G, Gresh L, Mohamed-Hadley A, Tellez Y, Sahoo MK, Abeynayake J, Balmaseda A, Harris E, Pinsky BA.

J Clin Virol. 2016 May;78:57-61. doi: 10.1016/j.jcv.2016.01.007. Epub 2016 Feb 27.

27.

Homotypic Dengue Virus Reinfections in Nicaraguan Children.

Waggoner JJ, Balmaseda A, Gresh L, Sahoo MK, Montoya M, Wang C, Abeynayake J, Kuan G, Pinsky BA, Harris E.

J Infect Dis. 2016 Oct 1;214(7):986-93. doi: 10.1093/infdis/jiw099. Epub 2016 Mar 16.

28.

Metabolomics-Based Discovery of Small Molecule Biomarkers in Serum Associated with Dengue Virus Infections and Disease Outcomes.

Voge NV, Perera R, Mahapatra S, Gresh L, Balmaseda A, Loroño-Pino MA, Hopf-Jannasch AS, Belisle JT, Harris E, Blair CD, Beaty BJ.

PLoS Negl Trop Dis. 2016 Feb 25;10(2):e0004449. doi: 10.1371/journal.pntd.0004449. eCollection 2016 Feb.

29.

Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype.

de Alwis R, Bangs DJ, Angelo MA, Cerpas C, Fernando A, Sidney J, Peters B, Gresh L, Balmaseda A, de Silva AD, Harris E, Sette A, Weiskopf D.

J Virol. 2016 Apr 14;90(9):4771-4779. doi: 10.1128/JVI.02892-15. Print 2016 May.

30.

The Timeline of Influenza Virus Shedding in Children and Adults in a Household Transmission Study of Influenza in Managua, Nicaragua.

Ng S, Lopez R, Kuan G, Gresh L, Balmaseda A, Harris E, Gordon A.

Pediatr Infect Dis J. 2016 May;35(5):583-6. doi: 10.1097/INF.0000000000001083.

31.

Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort.

Katzelnick LC, Montoya M, Gresh L, Balmaseda A, Harris E.

Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):728-33. doi: 10.1073/pnas.1522136113. Epub 2016 Jan 4.

32.

Chikungunya Virus Sequences Across the First Epidemic in Nicaragua, 2014-2015.

Wang C, Saborio S, Gresh L, Eswarappa M, Wu D, Fire A, Parameswaran P, Balmaseda A, Harris E.

Am J Trop Med Hyg. 2016 Feb;94(2):400-3. doi: 10.4269/ajtmh.15-0497. Epub 2015 Dec 7.

33.

Clinical Attack Rate of Chikungunya in a Cohort of Nicaraguan Children.

Balmaseda A, Gordon A, Gresh L, Ojeda S, Saborio S, Tellez Y, Sanchez N, Kuan G, Harris E.

Am J Trop Med Hyg. 2016 Feb;94(2):397-9. doi: 10.4269/ajtmh.15-0413. Epub 2015 Dec 7.

34.

The Nicaraguan pediatric influenza cohort study: design, methods, use of technology, and compliance.

Gordon A, Kuan G, Aviles W, Sanchez N, Ojeda S, Lopez B, Gresh L, Balmaseda A, Harris E.

BMC Infect Dis. 2015 Nov 9;15:504. doi: 10.1186/s12879-015-1256-6.

35.

Infectious Chikungunya Virus in the Saliva of Mice, Monkeys and Humans.

Gardner J, Rudd PA, Prow NA, Belarbi E, Roques P, Larcher T, Gresh L, Balmaseda A, Harris E, Schroder WA, Suhrbier A.

PLoS One. 2015 Oct 8;10(10):e0139481. doi: 10.1371/journal.pone.0139481. eCollection 2015.

36.

Burden of Influenza and Influenza-associated Pneumonia in the First Year of Life in a Prospective Cohort Study in Managua, Nicaragua.

Gresh L, Kuan G, Sanchez N, Azziz-Baumgartner E, Ojeda S, Melendez M, Lopez R, Martin ET, Widdowson MA, Bresee J, Harris E, Balmaseda A, Gordon A.

Pediatr Infect Dis J. 2016 Feb;35(2):152-6. doi: 10.1097/INF.0000000000000944.

37.

Human CD8+ T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated With Distinct Patterns of Protein Targets.

Weiskopf D, Cerpas C, Angelo MA, Bangs DJ, Sidney J, Paul S, Peters B, Sanches FP, Silvera CG, Costa PR, Kallas EG, Gresh L, de Silva AD, Balmaseda A, Harris E, Sette A.

J Infect Dis. 2015 Dec 1;212(11):1743-51. doi: 10.1093/infdis/jiv289. Epub 2015 May 15.

38.

Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections.

Grange L, Simon-Loriere E, Sakuntabhai A, Gresh L, Paul R, Harris E.

Front Immunol. 2014 Jun 11;5:280. doi: 10.3389/fimmu.2014.00280. eCollection 2014. Review.

39.

Selection of RNA aptamers against the M. tuberculosis EsxG protein using surface plasmon resonance-based SELEX.

Ngubane NA, Gresh L, Pym A, Rubin EJ, Khati M.

Biochem Biophys Res Commun. 2014 Jun 20;449(1):114-9. doi: 10.1016/j.bbrc.2014.04.163. Epub 2014 May 9.

PMID:
24813997
40.

Multiplex nucleic acid amplification test for diagnosis of dengue fever, malaria, and leptospirosis.

Waggoner JJ, Abeynayake J, Balassiano I, Lefterova M, Sahoo MK, Liu Y, Vital-Brazil JM, Gresh L, Balmaseda A, Harris E, Banaei N, Pinsky BA.

J Clin Microbiol. 2014 Jun;52(6):2011-8. doi: 10.1128/JCM.00341-14. Epub 2014 Mar 26.

41.

High-throughput sequencing enhanced phage display identifies peptides that bind mycobacteria.

Ngubane NA, Gresh L, Ioerger TR, Sacchettini JC, Zhang YJ, Rubin EJ, Pym A, Khati M.

PLoS One. 2013 Nov 12;8(11):e77844. doi: 10.1371/journal.pone.0077844. eCollection 2013.

42.

The Nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004-2010.

Gordon A, Kuan G, Mercado JC, Gresh L, Avilés W, Balmaseda A, Harris E.

PLoS Negl Trop Dis. 2013 Sep 26;7(9):e2462. doi: 10.1371/journal.pntd.0002462. eCollection 2013.

43.

Evaluation of the diagnostic utility of the traditional and revised WHO dengue case definitions.

Gutiérrez G, Gresh L, Pérez MÁ, Elizondo D, Avilés W, Kuan G, Balmaseda A, Harris E.

PLoS Negl Trop Dis. 2013 Aug 22;7(8):e2385. doi: 10.1371/journal.pntd.0002385. eCollection 2013.

44.

Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year.

Montoya M, Gresh L, Mercado JC, Williams KL, Vargas MJ, Gutierrez G, Kuan G, Gordon A, Balmaseda A, Harris E.

PLoS Negl Trop Dis. 2013 Aug 8;7(8):e2357. doi: 10.1371/journal.pntd.0002357. eCollection 2013.

45.

Comparison of the FDA-approved CDC DENV-1-4 real-time reverse transcription-PCR with a laboratory-developed assay for dengue virus detection and serotyping.

Waggoner JJ, Abeynayake J, Sahoo MK, Gresh L, Tellez Y, Gonzalez K, Ballesteros G, Guo FP, Balmaseda A, Karunaratne K, Harris E, Pinsky BA.

J Clin Microbiol. 2013 Oct;51(10):3418-20. doi: 10.1128/JCM.01359-13. Epub 2013 Jul 31.

46.

Single-reaction, multiplex, real-time rt-PCR for the detection, quantitation, and serotyping of dengue viruses.

Waggoner JJ, Abeynayake J, Sahoo MK, Gresh L, Tellez Y, Gonzalez K, Ballesteros G, Pierro AM, Gaibani P, Guo FP, Sambri V, Balmaseda A, Karunaratne K, Harris E, Pinsky BA.

PLoS Negl Trop Dis. 2013 Apr 18;7(4):e2116. doi: 10.1371/journal.pntd.0002116. Print 2013.

47.

Development of an internally controlled real-time reverse transcriptase PCR assay for pan-dengue virus detection and comparison of four molecular dengue virus detection assays.

Waggoner JJ, Abeynayake J, Sahoo MK, Gresh L, Tellez Y, Gonzalez K, Ballesteros G, Balmaseda A, Karunaratne K, Harris E, Pinsky BA.

J Clin Microbiol. 2013 Jul;51(7):2172-81. doi: 10.1128/JCM.00548-13. Epub 2013 May 1.

48.

Interstitial lung disease induced by gefitinib and toll-like receptor ligands is mediated by Fra-1.

Takada Y, Gresh L, Bozec A, Ikeda E, Kamiya K, Watanabe M, Kobayashi K, Asano K, Toyama Y, Wagner EF, Matsuo K.

Oncogene. 2011 Sep 8;30(36):3821-32. doi: 10.1038/onc.2011.101. Epub 2011 Apr 4.

PMID:
21460858
49.

Hepatocyte nuclear factor 1alpha and beta control terminal differentiation and cell fate commitment in the gut epithelium.

D'Angelo A, Bluteau O, Garcia-Gonzalez MA, Gresh L, Doyen A, Garbay S, Robine S, Pontoglio M.

Development. 2010 May;137(9):1573-82. doi: 10.1242/dev.044420.

50.

SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells.

Agrelo R, Souabni A, Novatchkova M, Haslinger C, Leeb M, Komnenovic V, Kishimoto H, Gresh L, Kohwi-Shigematsu T, Kenner L, Wutz A.

Dev Cell. 2009 Apr;16(4):507-16. doi: 10.1016/j.devcel.2009.03.006.

Supplemental Content

Support Center